Fundamentals · ABBV
Peer Comparison for ABBV
AI-generated plain-English read of peer comparison for ABBV. Updated daily.
Rich premium vs peers — in-line growth
lowABBV is priced at 4.87x the sector median with middling fundamentals — investors are paying up without a clear fundamental justification.
What to do
- If you HOLD this stock
- Hold a core position pending a clearer fundamental signal; the peer picture is mixed and doesn't strongly argue for adding or trimming.
- If you're EVALUATING this stock
- Mixed peer-relative picture. Build a half-position if the primary thesis is strong; wait for one more quarter of data before full sizing.
- If you trade OPTIONS
- Peer comparison alone doesn't point strongly in one direction. Let other signals (momentum, sentiment) determine directional bias; use spreads to limit premium outlay.
Only 6 peer(s) or 1 valuation metric(s) — the ranking can swing materially on a single data point.
Technical details
Technical analysis
- Sector
- Biotechnology
- Peer count
- 6
- Target P/E
- 105.9x
- Outlier flag
- Neutral
- Growth ranking
- In Line Growth
- Peer median P/E
- 21.8x
- Profitability rank
- In Line Prof
- Relative valuation
- Rich Premium
- Relative multiple (target / peer median)
- 4.87x
Key levels
| Level | Value |
|---|---|
| n peers | 6 |
| target pe | 105.938 |
| peer median pe | 21.752 |
| valuation ratio | 4.87 |
Caveats
- Peer comparisons are a single-snapshot read. Multi-quarter trends often matter more than current-quarter relative levels.